Fri, Jul 11, 2014, 3:04 AM EDT - U.S. Markets open in 6 hrs 26 mins


% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

  • catmandue007 catmandue007 Aug 15, 2013 12:15 AM Flag

    News on CMRX

    From Seeking Alpha alert: Chimerix anti-infection drug falls short in Phase II • 9:09 AM
    • Chimerix's (CMRX, -3.3%) CMX001 preemptive therapy for adenovirus (AdV) infection failed to achieve statistical significance in a Phase II trial of recipients of blood or bone marrow from donors.
    • However, Chimerix says that encouraging results from the first proof-of-concept study for adenovirus infection support the continued clinical development of CMX001.
    • AdV causes respiratory infections such as the common cold in healthy individuals. In patients with weakened immune systems, such as those who have recently received bone marrow or organ transplants, AdV infections have a high mortality rate.

2.72+0.02(+0.74%)Jul 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.